These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
75 related articles for article (PubMed ID: 2859032)
1. Metabolic effects of various beta-adrenoceptor blocking agents in rats and dogs. Traunecker W Arzneimittelforschung; 1985; 35(1A):376-82. PubMed ID: 2859032 [TBL] [Abstract][Full Text] [Related]
2. [Effects of various beta-receptor blockers on metabolic and circulatory parameters during physical exertion]. Koebe P; Rost R; Reinke A; Nagel N; Merten U Arzneimittelforschung; 1985; 35(2):522-9. PubMed ID: 2859861 [TBL] [Abstract][Full Text] [Related]
3. [Biochemical studies of acebutolol-the beta1 specificity of acebutolol (author's transl)]. Hamada Y; Sato I; Ito K; Kuwabara S; Kojima Y Nihon Yakurigaku Zasshi; 1977 Jul; 73(5):591-6. PubMed ID: 21835 [TBL] [Abstract][Full Text] [Related]
4. [Consequences of the administration of alpha or beta drenolytic agents on the mobilization of plasma free fatty acids as induced by noradrenaline and isoprenaline in the dog]. Berlan M C R Seances Soc Biol Fil; 1976 Oct; 170(3):672-9. PubMed ID: 10055 [TBL] [Abstract][Full Text] [Related]
5. A comparison of the cardioselectivity of five beta-adrenoceptor blocking drugs. Pringle TH; Riddell JG; Shanks RG J Cardiovasc Pharmacol; 1987 Aug; 10(2):228-37. PubMed ID: 2441175 [TBL] [Abstract][Full Text] [Related]
6. Beta-adrenoblocking activity of a new derivative of 2-aminotetraline based on some metabolic responses in cats and rats. Bogoslovova T; Staneva-Stoytcheva D Acta Physiol Pharmacol Bulg; 1988; 14(3):39-45. PubMed ID: 2906208 [TBL] [Abstract][Full Text] [Related]
7. Alterations in blood levels of carbohydrate and lipid metabolites and of cyclic AMP mediated by beta1- and beta2-adrenoceptors in beagle dogs: effects of procaterol, a new selective beta2-adrenoceptor agonist. Irie Y; Igawa T; Hosokawa T; Saitoh Y Eur J Pharmacol; 1979 Feb; 53(4):351-8. PubMed ID: 33812 [TBL] [Abstract][Full Text] [Related]
8. The assessment of the beta-adrenoceptor blocking activity and cardioselectivity of Koe 3290 in normal subjects. Pringle TH; McNeill AJ; Riddell JG; Shanks RG Br J Clin Pharmacol; 1987 Nov; 24(5):581-9. PubMed ID: 2893635 [TBL] [Abstract][Full Text] [Related]
9. Metabolic profile of beta-adrenoceptor-blocking action of befunolol. Maruyama Y; Awaji T; Inoue M; Takeo S Arch Int Pharmacodyn Ther; 1991; 311():73-88. PubMed ID: 1686392 [TBL] [Abstract][Full Text] [Related]
10. Effects of 1-(4-nitrophenyl)-2-isopropylaminoethanol (INPEA) and propranolol and their dextro-isomers on hemodynamic and metabolic responses to isoproterenol in dogs. Nishimura T; Kita S; Abiko Y J Pharmacol Exp Ther; 1983 Aug; 226(2):595-602. PubMed ID: 6688273 [TBL] [Abstract][Full Text] [Related]
11. Antihypertensive effects of 12 beta adrenoceptor antagonists in conscious spontaneously hypertensive rats: relationship to changes in plasma renin activity, heart rate and sympathetic nerve function. Antonaccio MJ; High J; DeForrest JM; Sybertz E J Pharmacol Exp Ther; 1986 Jul; 238(1):378-87. PubMed ID: 2873238 [TBL] [Abstract][Full Text] [Related]
12. [Bepridil, a functional antagonist of beta1-adrenergic stimulation. Dissociated effects on cardiostimulation and lipolysis. (author's transl)]. Constantin M; Beaughard M; Piris P; Labrid C J Pharmacol; 1981; 12(3):239-54. PubMed ID: 6116833 [TBL] [Abstract][Full Text] [Related]
13. The effects of beta-adrenoceptor blocking drugs on non-esterified fatty acid release from adipocytes. Harms HH J Pharmacol; 1983; 14 Suppl 2():209-15. PubMed ID: 6138469 [TBL] [Abstract][Full Text] [Related]
15. Effects of selective (beta-1 and beta-2) and nonselective beta adrenoceptor antagonists on the cardiovascular and metabolic responses to isoproterenol: comparison with ICI 141,292. Smith HJ; Halliday SE; Earl DC; Stribling D J Pharmacol Exp Ther; 1983 Jul; 226(1):211-6. PubMed ID: 6134820 [TBL] [Abstract][Full Text] [Related]
16. [Effects of adrenergic blockade on adipose tissue lipolysis provoked in cats and humans by intravenous perfusion of isoprenaline]. Ashford A Nouv Presse Med; 1975 Dec; 4(46 Suppl):3265-7. PubMed ID: 3767 [TBL] [Abstract][Full Text] [Related]
17. L-3,4-(3-3,4-dimethoxyphenethylamino-2-hydroxypropoxy)-phenyl- crotonic acid nitrile.HCl (Hoe 224), a beta-blocking agent with high beta 1-selectivity. Lindner E Arzneimittelforschung; 1984; 34(3):270-6. PubMed ID: 6145430 [TBL] [Abstract][Full Text] [Related]
18. Study of the metabolic effects of bunitrolol (Koe 1366) in angina induced by catecholamine infusion. Cuccurullo F; Masi M; Mezzetti A; Rosini R; Luciani G; Tomassetti V; Abate G; Lenzi S Arzneimittelforschung; 1979; 29(1):138-41. PubMed ID: 36102 [TBL] [Abstract][Full Text] [Related]
19. Metabolic consequences of beta-adrenergic receptor blockade for the acutely ischemic dog myocardium. Westera G; van der Wall EE; van Eenige MJ; Scholtalbers S; den Hollander W; Visser FC; Roos JP Nuklearmedizin; 1984 Feb; 23(1):35-40. PubMed ID: 6145147 [TBL] [Abstract][Full Text] [Related]
20. [Influence of alpha or beta adrenergic antagonists on catecholamine dependent metabolic effects in pigs]. Brenner KV; Gürtler H Acta Biol Med Ger; 1981; 40(12):1759-66. PubMed ID: 6125073 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]